References
1. Dayan CM. Interpretation of thyroid function tests. Lancet 2001;357:619–624.
2. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–126.
3. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017;27:315–389.
4. Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol 2015;3:816–825.
5. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995;333:1688–1694.
6. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472–4479.
7. Yi KH, Moon JH, Kim IJ, Bom HS, Lee J, Chung WY, Chung JH, Shong YK. The diagnosis and management of hyperthyroidism consensus: report of the Korean Thyroid Association. J Korean Thyroid Assoc 2013;6:1–11.
8. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016;388:906–918.
9. Smith TJ, Hegedus L. Graves’ disease. N Engl J Med 2016;375:1552–1565.
10. Ralls PW, Mayekawa DS, Lee KP, Colletti PM, Radin DR, Boswell WD, Halls JM. Color-flow Doppler sonography in Graves disease: “thyroid inferno”. AJR Am J Roentgenol 1988;150:781–784.
11. Lee SM, Kim SK, Hahm JR, Jung JH, Kim HS, Kim S, Chung SI, Choi BH, Jung TS. Differential diagnostic value of total T3/free T4 ratio in Graves’ disease and painless thyroiditis presenting thyrotoxicosis. Endocrinol Metab 2012;27:121–125.
12. Toft AD. Clinical practice: subclinical hyperthyroidism. N Engl J Med 2001;345:512–516.
13. Lania A, Persani L, Beck-Peccoz P. Central hypothyroidism. Pituitary 2008;11:181–186.
14. Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P. Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 2000;85:3631–3635.
15. Abucham J, Castro V, Maccagnan P, Vieira JG. Increased thyrotrophin levels and loss of the nocturnal thyrotrophin surge in Sheehan's syndrome. Clin Endocrinol (Oxf) 1997;47:515–522.
16. Oliveira JH, Persani L, Beck-Peccoz P, Abucham J. Investigating the paradox of hypothyroidism and increased serum thyrotropin (TSH) levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. J Clin Endocrinol Metab 2001;86:1694–1699.
17. Erfurth EM, Hedner P. Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine. J Endocrinol Invest 1986;9:407–412.
18. Peeters RP. Subclinical hypothyroidism. N Engl J Med 2017;376:2556–2565.
19. Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL. 2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2013;2:76–82.
20. Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol 2014;10:582–591.
21. Kim HK, Kim D, Yoo EH, Lee JI, Jang HW, Tan AH, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW. A case of resistance to thyroid hormone with thyroid cancer. J Korean Med Sci 2010;25:1368–1371.
22. Kim JH, Park TS, Baek HS, Kim GH, Yoo HW, Park JH. A newly identified insertion mutation in the thyroid hormone receptor-beta gene in a Korean family with generalized thyroid hormone resistance. J Korean Med Sci 2007;22:560–563.
23. Yi KH, Kim KW, Yim CH, Jung ED, Chung JH, Chung HK, Hong SC, Chung JH. Guidelines for the diagnosis and management of thyroid disease during pregnancy and postpartum. J Korean Thyroid Assoc 2014;7:7–39.
24. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM. American Thyroid Association Task Force on Thyroid Hormone Replacement. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 2014;24:1670–1751.
25. Kim HI, Kim TH, Kim H, Kim YN, Jang HW, Chung JH, Moon SM, Jhun BW, Lee H, Koh WJ, Kim SW. Effect of rifampin on thyroid function test in patients on levothyroxine medication. PLoS One 2017;12:e0169775.
26. Illouz F, Braun D, Briet C, Schweizer U, Rodien P. Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors. Eur J Endocrinol 2014;171:R91–R99.
27. Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol (Oxf) 2016;85:331–339.
28. Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. Factitious Graves’ disease due to biotin immunoassay interference-a case and review of the literature. J Clin Endocrinol Metab 2016;101:3251–3255.
29. Kummer S, Hermsen D, Distelmaier F. Biotin treatment mimicking Graves’ disease. N Engl J Med 2016;375:704–706.